期刊文献+

血清前列腺特异性抗原4~10μg/L患者前列腺穿刺活检的临床意义 被引量:1

下载PDF
导出
摘要 目前临床主要采用直肠指检(DRE)、血清前列腺特异性抗原(PSA)、经直肠超声(TRUS)、前列腺穿刺活检等进行前列腺癌临床筛查和诊断。其中,前列腺穿刺活检是目前诊断前列腺癌的金标准。
出处 《山西医药杂志(上半月)》 CAS 2011年第4期392-393,共2页 Shanxi Medical Journal
  • 相关文献

参考文献3

二级参考文献11

  • 1Greenlee RT, Murray, Bolden, et al. Cancer statistics. CA Cancer J clin,2001,51 : 15-36.
  • 2Lee F, Torp Pedersen ST, Siders DB, et al. Transrectal ultrasound in diagnosis and staging of prostatic carcinoma. Radiology, 1959,170 : 609-615.
  • 3Kravchick S, Cytron S, Pytel A, et al. Improved detection of clinically significant curable prostate cancer with systematicl2 corebiopsy. TU rol,2004,171:1089.
  • 4Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy:a prospective study and review of the literature. J Urol, 1998,160:2115-2120.
  • 5P Vassilis,W Ulrich,D Vries,et al.Preoperative neural network using combined magnetic resonance imaging variables,prostate specific antigen and gleason score to predict prostate cancer stage.J Urol,2004,172:1306-1310.
  • 6F Recker,M Kwiatkowski:PSA-screning for prostate cancer-yes or no? Ther Umsch,2004,61:875-878.
  • 7Jeng HS,Huang SP,Chou YH,et al.Detection of prostate cancer-experience of seven years in KMUH and review of literature.Kaohsiung J Med Sci,2002,18:281-288.
  • 8AV IAmico,A Desjardin,MH Chen,et al.Analyzing outcome-based staging for clinically localized adenocarcinoma of the prostate.Cancer,1998,83:2172-2180.
  • 9Susand S,Erik B,Jeffrey S,et al.Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical gleason score and patient age.J Urol,2002,168:525-529.
  • 10Young HH.The early diagnosis and radical cure of carcinoma of the prostate.Bulletin of the Johns Hopkins Hospital 1995,315-321.

共引文献12

同被引文献16

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部